María José Alonso Fernández

María José Alonso Fernandez (born 22 December 1958) is a full professor of biopharmaceutics and pharmaceutical technology at the University of Santiago de Compostela. The laboratory she leads is specialized in pharmaceutical nanotechnology and nanomedicine, and her research is oriented to the development of nanostructures for targeted delivery of drugs and vaccines. Her discoveries have led to significant clinical advances in the development of potential new treatments for cancer, ocular diseases, skin diseases, diabetes, obesity and other autoimmune pathologies, as well as new vaccines.

Professional experience and scientific career María José Alonso has a master's degree in pharmacy (University of Santiago de Compostela – USC, 1985) and a PhD in pharmaceutical technology (USC, 1985). She has also developed her research career at the University of Paris XI and at the University of Angers (France), as well as in the Massachusetts Institute of Technology (MIT).

In 2006–2010 she held the responsibility of Vicerrector of Research and Innovation at the University of Santiago de Compostela. In this role she created a network of research institutes that contributed to the recognition of "Campus of Excellence" by the Ministry of Sciences and Innovation.

She is a member of the National Academy of Medicine (U.S.), a member of the Royal Academy of Medicine of Belgium, and a member of three academies in Spain (Real Academia Nacional de Farmacia, Real Academia de Farmacia de Galicia and Real Academia Galega de Ciencias ).

Alonso has held responsibilities in several scientific societies, among them the Controlled Release Society. She first contributed to the CRS as the founder of the Spanish-Portuguese Local Chapter (1994), and later she was Governor, Director-at-Large, Secretary and President of this society. Moreover, she is part of the editorial board of 11 scientific journals, and editor-in-chief of the Drug Delivery and Translational Research.

She has coordinated and participated in several research consortia financed by the World Health Organization (WHO), the Bill and Melinda Gates Foundation and the European Commission.

She is the most influential researcher in Spain in the area of pharmacology and pharmacy (h-index), and is also classified among the top ten researchers in her field worldwide (Times Higher Education Ranking).

Drug delivery research María José Alonso's Lab is focused on designing novel nanostructured materials intended to transport drugs and antigens across biological barriers (such as cellular, ocular, nasal, skin and intestinal barriers) and deliver them to the target tissue. Alonso's research is specialized in the association of biological compounds, including drugs and antigens to these nanovehicles, with the final goal of producing innovative nanomedicines and vaccines.

Awards and recognitions 1985: Extraordinary PhD award for the best PhD of the Faculty of Pharmacy, USC. 1982: Eloy Díez Award granted by the Eloy Díez Foundation to the best PhD of the year. 2010: Member of the Galician Academy of Pharmacy (Spain) 2010: Member of the Spanish Royal Academy of Pharmacy (Spain) 2011: "Novoa Santos" Award 2011: "King Jaume I" Award on New Technologies 2012: Medal of the General Council of Pharmacy 2013: "Women in Sciences" Award granted by Xunta de Galicia 2014: "Maurice Marie Janot Award" granted by the European Pharmaceutical Society (APGI) 2014: Member of the Royal Academy of Sciences of Galicia (Spain) 2016: Member of the National Academy of Medicine (U.S.) 2017: Member of the American Institute for Medical and Biological Engineering’s College of Fellows (AIMBE) (U.S.) 2018: "Castelao Medal", awarded by Xunta de Galicia 2018: Member of the College of Fellows of the Controlled Release Society 2018: "CRS Founders Award", granted by the Controlled Release Society 2020: "The Power List" of the 20 most influential researchers in biopharmaceuticals, published by The Medicine Maker 2020: "Distinguished Service Award", granted by the Controlled Release Society, Inc. (CRS, Inc) 2020: "Women in Science Award", granted by the Controlled Release Society, Inc. (CRS, Inc) 2020: "Gold Medal of Merit in Research and University Education", granted by the Ministry of Science and Innovation (Government of Spain) 2021: Member of the Royal Academy of Medicine of Belgium 2022: National Research Award ‘Juan de la Cierva’, granted by the Spanish Ministry of Science and Innovation 2022: Doctor “Honoris Causa”, University of Nottingham 2022: “ASEICA Woman and Science 2022” and “ASEICA Social Commitment” Award, Spanish Association for Cancer Research 2022: "Doctora de Alcalá Award", granted by University of Alcala de Henares 2024: Member of the Academy of Pharmacy and Biochemistry, Argentina 2025: "Hamilton Medal", awarded by Queens University of Belfast 2025: Doctor “Honoris Causa”, University of Cordoba (Argentina) 2025: Doctor "Honoris Causa", University of Buenos Aires 2025: Membre Associé of the Académie Nationale de Pharmacie of France

Journal associations Pharmaceutical Research Journal of Controlled Release International Journal of Pharmaceutics European Journal of Pharmaceutics and Biopharmaceutics European Journal of Pharmaceutical Sciences Drug Development and Industrial Pharmacy Drug Delivery Sciences & Technologies Journal of Microencapsulation Nanomedicine Regenerative Engineering and Translational Medicine Drug Delivery and Translational Research (Editor-in-Chief) Masticadoresfem, 17 September 2021. (Spanish)